MedTrace Logo

Evaluate the Safety And Efficacy of the Transradial Coronary in Comparison With the Transfemoral Coronary Intervention

NCT01704911 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1700

Last updated 2012-10-26

No results posted yet for this study

Summary

The purpose of the DRAGON clinical trial is to evaluate the safety and efficacy of the transradial coronary intervention (TRI) in comparison with the transfemoral coronary intervention (TFI).

Conditions

  • Free Rate of Cardiac or Cerebrovascular Events
  • Transradial-transfemoral Coronary Interventions Comparison

Interventions

PROCEDURE

Transradial Coronary Intervention

PROCEDURE

Transfemoral Coronary Intervention

DEVICE

Coronary Stent System

Any kind of coronary stent system

Sponsors & Collaborators

  • Peking University First Hospital

    collaborator OTHER

  • Terumo Medical (Shanghai) Co.,Ltd.

    collaborator INDUSTRY

  • CCRF Consulting Co., Ltd.

    lead OTHER

Principal Investigators

  • Shigeru Saito, MD · Shonan Kamakura General Hospital, Japan

  • Yong Huo, MD · Peking University First Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2014-12-31
Completion
2015-03-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01704911 on ClinicalTrials.gov